Published in Women's Health Weekly, April 10th, 2003
The mouse model provides a better opportunity to study the cause of ovarian cancer, examine the genes involved, and test preventive, diagnostic and treatment approaches that could be applied to human ovarian cancer.
"These transgenic mice offer us a valuable scientific tool that never before has been available to ovarian cancer researchers," explained Fox Chase Cancer Center's Denise C. Connolly, PhD, corresponding author of the study, which appears in Cancer...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.